• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可吸收镁支架的早期再狭窄:光学相干断层成像的发现。

Early restenosis of resorbable magnesium scaffolds: Optical coherence tomography findings.

机构信息

Cardiology Department, Hospital Universitario de La Princesa, Madrid, Spain.

Instituto de Investigación Sanitaria Hospital Universitario de La Princesa, Madrid, Spain.

出版信息

Catheter Cardiovasc Interv. 2019 Jan 1;93(1):79-81. doi: 10.1002/ccd.27871. Epub 2018 Sep 23.

DOI:10.1002/ccd.27871
PMID:30244535
Abstract

Resorbable Magnesium Scaffolds (RMS) represent an interesting alternative to current drug-eluting stents. Current data from clinical trials seems to confirm good performance of these new devices with low rates of late device failure. Little is known about mechanisms leading to RMS failure. Herein, we present the first description of an early RMS in-scaffold restenosis. Optical coherence tomography (OCT) analysis at implantation detected acute non-severe malapposition and underexpansion as main promoters of RMS failure. OCT during in-scaffold restenosis intervention confirmed early severe neointimal proliferation and RMS late recoil and dismantling as the main mechanisms of device failure. We hypothesize that the fast resorption process of RMS may lead to an early loss of radial strength, that could favor late recoil, acquired underexpansion, device dismantling and might interact with distribution of sirolimus. This case also illustrates that OCT is pivotal to unravel both acute and acquired mechanisms related to RMS failure.

摘要

可吸收镁支架(RMS)是目前药物洗脱支架的一种很有前途的替代品。目前临床试验的数据似乎证实了这些新型器械具有良好的性能,晚期器械失败的发生率较低。但是,导致 RMS 失败的机制知之甚少。本文首次描述了一种早期 RMS 支架内再狭窄。植入时的光学相干断层扫描(OCT)分析发现急性非严重贴壁不良和扩张不足是 RMS 失败的主要原因。在支架内再狭窄介入期间进行的 OCT 检查证实了早期严重的新生内膜增殖以及 RMS 晚期的回缩和解体是器械失败的主要机制。我们假设 RMS 的快速吸收过程可能导致早期丧失径向强度,从而导致晚期回缩、获得性扩张不足、器械解体,并可能与西罗莫司的分布相互作用。该病例还表明,OCT 对于揭示与 RMS 失败相关的急性和获得性机制至关重要。

相似文献

1
Early restenosis of resorbable magnesium scaffolds: Optical coherence tomography findings.可吸收镁支架的早期再狭窄:光学相干断层成像的发现。
Catheter Cardiovasc Interv. 2019 Jan 1;93(1):79-81. doi: 10.1002/ccd.27871. Epub 2018 Sep 23.
2
Severe focal restenosis 15 months after implantation of a magnesium bioresorbable scaffold.镁生物可吸收支架植入15个月后出现严重局灶性再狭窄。
Acta Cardiol. 2020 Feb;75(1):85-86. doi: 10.1080/00015385.2018.1548109. Epub 2019 Feb 8.
3
Magmaris very late in-scaffold restenosis: Has the "black boxes" nightmare come back?玛格瑞斯支架内晚期再狭窄:“黑箱”噩梦重现?
Catheter Cardiovasc Interv. 2020 Aug;96(2):E174-E176. doi: 10.1002/ccd.28608. Epub 2019 Nov 25.
4
Two-Year Follow-Up OCT Images of 2 Bifurcation Lesions Treated With Bioresorbable Vascular Scaffolds.
JACC Cardiovasc Imaging. 2015 May;8(5):617-618. doi: 10.1016/j.jcmg.2014.07.025. Epub 2014 Nov 26.
5
Evaluation of Early Healing Profile and Neointimal Transformation Over 24 Months Using Longitudinal Sequential Optical Coherence Tomography Assessments and 3-Year Clinical Results of the New Dual-Therapy Endothelial Progenitor Cell Capturing Sirolimus-Eluting Combo Stent: The EGO-Combo Study.使用纵向序列光学相干断层扫描评估新的双疗法内皮祖细胞捕获西罗莫司洗脱组合支架24个月内的早期愈合情况和新生内膜转化以及3年临床结果:EGO组合研究
Circ Cardiovasc Interv. 2016 Jul;9(7). doi: 10.1161/CIRCINTERVENTIONS.115.003469.
6
First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.第二代可吸收依维莫司洗脱生物可吸收血管支架的 6 个月和 2 年的首次系列评估:多模态影像学研究。
Circ Cardiovasc Interv. 2012 Oct;5(5):620-32. doi: 10.1161/CIRCINTERVENTIONS.112.971549. Epub 2012 Oct 9.
7
Challenging treatment of in-stent restenosis in a coronary bifurcation by implantation of a bioresorbable scaffold under optical coherence tomography guidance.在光学相干断层扫描引导下植入生物可吸收支架治疗冠状动脉分叉处支架内再狭窄的挑战性治疗
Cardiol J. 2019;26(3):304-306. doi: 10.5603/CJ.2019.0063.
8
Severe Neointimal Hyperplasia of Neoplastic Carina Following Bioresorbable Scaffold Implantation Using T-Stenting and Small Protrusion Technique: Insights From Optical Frequency Domain Imaging.使用T型支架和小突出技术植入生物可吸收支架后肿瘤隆突处的严重新生内膜增生:来自光学频域成像的见解
JACC Cardiovasc Interv. 2015 Nov;8(13):e207-9. doi: 10.1016/j.jcin.2015.05.031. Epub 2015 Oct 14.
9
Serial invasive imaging follow-up of the first clinical experience with the Magmaris magnesium bioresorbable scaffold.玛格瑞斯镁可吸收支架首例临床应用的系列有创影像学随访。
Catheter Cardiovasc Interv. 2020 Feb;95(2):226-231. doi: 10.1002/ccd.28304. Epub 2019 Apr 29.
10
Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.紫杉醇洗脱球囊后扩张与依维莫司洗脱支架治疗裸金属支架:使用光学相干断层成像术在 6 个月随访时的前瞻性随机研究。
Circ Cardiovasc Interv. 2014 Dec;7(6):760-7. doi: 10.1161/CIRCINTERVENTIONS.113.001146. Epub 2014 Nov 4.

引用本文的文献

1
BIOSOLVE-IV-registry: Safety and performance of the Magmaris scaffold: 12-month outcomes of the first cohort of 1,075 patients.BIOSOLVE-IV 注册研究:Magmaris 支架的安全性和性能:1075 例患者的首个队列 12 个月结果。
Catheter Cardiovasc Interv. 2021 Jul 1;98(1):E1-E8. doi: 10.1002/ccd.29260. Epub 2020 Sep 3.